Research from Ningbo Medical Center Lihuili Hospital Provides New Data on Bladder Cancer (Identification of m6A suppressor EIF4A3 as a novel cancer prognostic and immunotherapy biomarker through bladder cancer clinical data validation and...).

Keywords: Biomarkers; Bladder Cancer; Cancer; Data Validation; Diagnostics and Screening; Drugs and Therapies; Genetics; Health and Medicine; Immunotherapy; Information Technology; Information and Data Validation; Oncology EN Biomarkers Bladder Cancer Cancer Data Validation Diagnostics and Screening Drugs and Therapies Genetics Health and Medicine Immunotherapy Information Technology Information and Data Validation Oncology 882 882 1 10/16/23 20231017 NES 231017 2023 OCT 17 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- New research on bladder cancer is the subject of a new report. For more information on this research see: Identification of m6A suppressor EIF4A3 as a novel cancer prognostic and immunotherapy biomarker through bladder cancer clinical data validation and pan-cancer analysis. [Extracted from the article]

Copyright of Immunotherapy Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)